Visionary scientist-entrepreneur with a 25+ year track record of pioneering innovations in diagnostics, molecular biology, and life science commercialization

Founder of CYTO Consulting, a firm that has helped dozens of international life science companies establish and grow their U.S. footprint

Known for bridging cutting-edge research with real-world clinical applications—particularly in cardiovascular diagnostics, microfluidics, and molecular testing

Senior leadership experience at global life sciences companies:

Agilent Technologies (1997–2010): Led development of the company’s first FDA-cleared diagnostic test; key figure in cardiovascular and infectious disease assay strategies

Merck Millipore (2010–2013): Drove double-digit growth and transformed antibody product strategy

Danaher / AB Sciex (2014–2015): Directed global clinical business unit; launched CE-marked kits across multiple regions

Abcam (2016–2017): Built custom solutions and licensing business from the ground up

Internationally recognized for his contributions to diagnostics innovation, with multiple patents, peer-reviewed publications, and a global professional network

Fluent in science and strategy, Odilo excels in turning scientific breakthroughs into commercial success

Education: Ph.D. and M.S. – Northeastern University (Magna Cum Laude) | B.S. – Universität des Saarlandes, Germany